Friday, May 8, 2020

Moderna (MRNA) Rockets After FDA News. Is MRNA a Buy?

Moderna (NASDAQ: MRNA), pharmaceutical giant, is on its second stage of coronavirus vaccine. mRNA shares – to date – have risen nearly 160%. The company is one of a handful of biotechnologists working on a …


from
https://alphabetastock.com/2020/05/08/moderna-mrna-rockets-after-fda-news/

No comments:

Post a Comment